Schedule 13G ownership disclosure

INTRA-CELLULAR THERAPIES INC

Security class unavailable · CUSIP: 46116X101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,876,201
Percent of class
8.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-017840
Form type
SC 13G/A
Filer
Intra-Cellular Therapies, Inc.
CIK
CIK 1567514
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub